| Product Code: ETC7636596 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of PD-1 and PD-L1 inhibitors to Ireland in 2024 saw a significant increase in concentration, with Germany, UK, USA, Canada, and other areas being the top exporting countries. The Herfindahl-Hirschman Index (HHI) indicated a shift from moderate to high concentration in 2024, reflecting a more focused market landscape. The impressive compound annual growth rate (CAGR) of 23.25% from 2020 to 2024 underscores the growing demand for these inhibitors. Moreover, the exceptional growth rate of 68.68% from 2023 to 2024 highlights a rapid acceleration in import activity within this sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland PD-1 and PD-L1 Inhibitors Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland PD-1 and PD-L1 Inhibitors Market - Industry Life Cycle |
3.4 Ireland PD-1 and PD-L1 Inhibitors Market - Porter's Five Forces |
3.5 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Inhibitors, 2022 & 2032F |
3.6 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Ireland PD-1 and PD-L1 Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Ireland |
4.2.2 Growing demand for innovative cancer treatments |
4.2.3 Favorable government initiatives supporting immunotherapy research and development |
4.3 Market Restraints |
4.3.1 High cost associated with PD-1 and PD-L1 inhibitors |
4.3.2 Stringent regulatory approval process for new drugs |
4.3.3 Limited awareness among healthcare professionals and patients about immunotherapy options |
5 Ireland PD-1 and PD-L1 Inhibitors Market Trends |
6 Ireland PD-1 and PD-L1 Inhibitors Market, By Types |
6.1 Ireland PD-1 and PD-L1 Inhibitors Market, By Inhibitors |
6.1.1 Overview and Analysis |
6.1.2 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Inhibitors, 2022 - 2032F |
6.1.3 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-1 Inhibitors, 2022 - 2032F |
6.1.4 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By PD-L1 Inhibitors, 2022 - 2032F |
6.2 Ireland PD-1 and PD-L1 Inhibitors Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hodgkin Lymphoma, 2022 - 2032F |
6.2.3 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Kidney Cancer, 2022 - 2032F |
6.2.4 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Melanoma, 2022 - 2032F |
6.2.5 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Non-small Cell Lung Cancer, 2022 - 2032F |
6.2.6 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Other Applications, 2022 - 2032F |
6.3 Ireland PD-1 and PD-L1 Inhibitors Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.3.3 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
6.3.4 Ireland PD-1 and PD-L1 Inhibitors Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
7 Ireland PD-1 and PD-L1 Inhibitors Market Import-Export Trade Statistics |
7.1 Ireland PD-1 and PD-L1 Inhibitors Market Export to Major Countries |
7.2 Ireland PD-1 and PD-L1 Inhibitors Market Imports from Major Countries |
8 Ireland PD-1 and PD-L1 Inhibitors Market Key Performance Indicators |
8.1 Number of ongoing clinical trials for PD-1 and PD-L1 inhibitors in Ireland |
8.2 Percentage of cancer patients opting for immunotherapy treatments |
8.3 Rate of adoption of PD-1 and PD-L1 inhibitors in different cancer types |
9 Ireland PD-1 and PD-L1 Inhibitors Market - Opportunity Assessment |
9.1 Ireland PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Inhibitors, 2022 & 2032F |
9.2 Ireland PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 Ireland PD-1 and PD-L1 Inhibitors Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Ireland PD-1 and PD-L1 Inhibitors Market - Competitive Landscape |
10.1 Ireland PD-1 and PD-L1 Inhibitors Market Revenue Share, By Companies, 2025 |
10.2 Ireland PD-1 and PD-L1 Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here